• 提示：詳情請(qǐng)下載說(shuō)明書。

• 產(chǎn)品描述：

  Balsalazide could suppress colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway.

• 靶點(diǎn)： IL-6;IL-1;STAT3;Lipoxygenase;STAT;Interleukin

• 體內(nèi)研究：
  At the endpoint, the protein production of MIP-1β, MCP-1, IL-6, and IL-10 in the colon tissues decrease in concordance with the plasma concentrations of the cytokines. The drug-treated groups reveal lower expression of p-STAT3 compared to the CAC group. In addition, BCL2 decreases and BAX increases markedly in the BSZ+VSL#3 group. Balsalazide is a new 5-aminosalicylic acid (5-ASA) containing prodrug

• 參考文獻(xiàn)：
  1. Do EJ, et al. Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3. J Gastroenterol Hepatol. 2016 Aug;31(8):1453-61. 2. Kruis W, et al. Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses. Gut, 2001. 49(6): p. 783-789.

• 溶解性： Soluble  in  DMSO、1M  NaOH

• 保存條件： 2-8℃

• 配置溶液濃度參考：
  

  	1mg	5mg	10mg
  1 mM	2.799 ml	13.993 ml	27.986 ml
  5 mM	0.56 ml	2.799 ml	5.597 ml
  10 mM	0.28 ml	1.399 ml	2.799 ml
  50 mM	0.056 ml	0.28 ml	0.56 ml

• 注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。

輸入產(chǎn)品批號(hào)：

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系，公式為：

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

• pg ng μg mg g kg =
  fM pM nM μM mM M *
  nL μL mL L *